luspatercept
ItalyDrugs containing this active substance
-
It is used to treat anemia in adults with myelodysplastic syndromes (MDS) or beta-thalassemia. The drug helps the body produce more red blood cells, improving hemoglobin levels and, in patients with MDS, can reduce the need for blood transfusions.
Form: powder for solution for injection
Active substance Dosage luspatercept - ATC: B03XA06
Manufacturer: BRISTOL-MYERS SQUIBB PHARMA EEIG